Industry Research Reports
Home > Reports > Food & Beverages > OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Food & Beverages
Published Date: 2026-01-19
Pages: 123 Pages
Report ld: 5779601
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
OPO-containing Infant Formulas Market Size(US$)
CAGR 2026-2032
5.0%
Market Size,2032
USD 1,564
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,167 million
Market Forecast in 2032(Value)
US$ 1,564 million
CAGR
5.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on OPO-containing Infant Formulas cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
The North American market for OPO-containing Infant Formulas was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for OPO-containing Infant Formulas was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for OPO-containing Infant Formulas was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the OPO-containing Infant Formulas market include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for OPO-containing Infant Formulas, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The OPO-containing Infant Formulas market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding OPO-containing Infant Formulas.
MARKET SEGMENTATION
By Company
- BiosTime
- Nutriben
- Ausnutria
- HERDS
- Milupa
- Shanxi Yatai
- Beingmate
- Abbott
- Brightdairy
- Feihe
- Wyeth Nutrition
- Deloraine
- Yili
- Kabrita
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cow Milk Formula
- Goat Milk Formula
Segment by Application
- 0 - 6 Month
- 6 - 12 Month
- 12 - 36 Month
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the OPO-containing Infant Formulas manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents OPO-containing Infant Formulas sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents OPO-containing Infant Formulas sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 OPO-containing Infant Formulas Product Introduction
1.2 Global OPO-containing Infant Formulas Market Size Forecast
1.2.1 Global OPO-containing Infant Formulas Sales Value (2021–2032)
1.2.2 Global OPO-containing Infant Formulas Sales Volume (2021–2032)
1.2.3 Global OPO-containing Infant Formulas Sales Price (2021–2032)
1.3 OPO-containing Infant Formulas Market Trends & Drivers
1.3.1 OPO-containing Infant Formulas Industry Trends
1.3.2 OPO-containing Infant Formulas Market Drivers & Opportunities
1.3.3 OPO-containing Infant Formulas Market Challenges
1.3.4 OPO-containing Infant Formulas Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global OPO-containing Infant Formulas Players Revenue Ranking (2025)
2.2 Global OPO-containing Infant Formulas Revenue by Company (2021–2026)
2.3 Global OPO-containing Infant Formulas Sales Volume Ranking of Players (2025)
2.4 Global OPO-containing Infant Formulas Sales Volume by Company (2021–2026)
2.5 Global OPO-containing Infant Formulas Average Price by Company (2021–2026)
2.6 Key Manufacturers OPO-containing Infant Formulas Manufacturing Base and Headquarters
2.7 Key Manufacturers OPO-containing Infant Formulas Product Offerings
2.8 Key Manufacturers Start of Mass Production of OPO-containing Infant Formulas
2.9 OPO-containing Infant Formulas Market Competitive Analysis
2.9.1 OPO-containing Infant Formulas Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by OPO-containing Infant Formulas Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on OPO-containing Infant Formulas revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation OPO-containing Infant Formulas Market Classification
3.1 Introduction by Type
3.1.1 Cow Milk Formula
3.1.2 Goat Milk Formula
3.1.3 Global OPO-containing Infant Formulas Sales Value by Type
3.1.3.1 Global OPO-containing Infant Formulas Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global OPO-containing Infant Formulas Sales Value, by Type (2021–2032)
3.1.3.3 Global OPO-containing Infant Formulas Sales Value, by Type (%), 2021–2032
3.1.4 Global OPO-containing Infant Formulas Sales Volume by Type
3.1.4.1 Global OPO-containing Infant Formulas Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global OPO-containing Infant Formulas Sales Volume, by Type (2021–2032)
3.1.4.3 Global OPO-containing Infant Formulas Sales Volume, by Type (%), 2021–2032
3.1.5 Global OPO-containing Infant Formulas Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 0 - 6 Month
4.1.2 6 - 12 Month
4.1.3 12 - 36 Month
4.2 Global OPO-containing Infant Formulas Sales Value by Application
4.2.1 Global OPO-containing Infant Formulas Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global OPO-containing Infant Formulas Sales Value, by Application (2021–2032)
4.2.3 Global OPO-containing Infant Formulas Sales Value, by Application (%), 2021–2032
4.3 Global OPO-containing Infant Formulas Sales Volume by Application
4.3.1 Global OPO-containing Infant Formulas Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global OPO-containing Infant Formulas Sales Volume, by Application (2021–2032)
4.3.3 Global OPO-containing Infant Formulas Sales Volume, by Application (%), 2021–2032
4.4 Global OPO-containing Infant Formulas Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global OPO-containing Infant Formulas Sales Value by Region
5.1.1 Global OPO-containing Infant Formulas Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global OPO-containing Infant Formulas Sales Value by Region (2021–2026)
5.1.3 Global OPO-containing Infant Formulas Sales Value by Region (2027–2032)
5.1.4 Global OPO-containing Infant Formulas Sales Value by Region (%), 2021–2032
5.2 Global OPO-containing Infant Formulas Sales Volume by Region
5.2.1 Global OPO-containing Infant Formulas Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global OPO-containing Infant Formulas Sales Volume by Region (2021–2026)
5.2.3 Global OPO-containing Infant Formulas Sales Volume by Region (2027–2032)
5.2.4 Global OPO-containing Infant Formulas Sales Volume by Region (%), 2021–2032
5.3 Global OPO-containing Infant Formulas Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America OPO-containing Infant Formulas Sales Value, 2021–2032
5.4.2 North America OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe OPO-containing Infant Formulas Sales Value, 2021–2032
5.5.2 Europe OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific OPO-containing Infant Formulas Sales Value, 2021–2032
5.6.2 Asia Pacific OPO-containing Infant Formulas Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America OPO-containing Infant Formulas Sales Value, 2021–2032
5.7.2 South America OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa OPO-containing Infant Formulas Sales Value, 2021–2032
5.8.2 Middle East & Africa OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions OPO-containing Infant Formulas Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions OPO-containing Infant Formulas Sales Value and Sales Volume
6.2.1 Key Countries/Regions OPO-containing Infant Formulas Sales Value, 2021–2032
6.2.2 Key Countries/Regions OPO-containing Infant Formulas Sales Volume, 2021–2032
6.3 United States
6.3.1 United States OPO-containing Infant Formulas Sales Value, 2021–2032
6.3.2 United States OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.3.3 United States OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe OPO-containing Infant Formulas Sales Value, 2021–2032
6.4.2 Europe OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China OPO-containing Infant Formulas Sales Value, 2021–2032
6.5.2 China OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.5.3 China OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan OPO-containing Infant Formulas Sales Value, 2021–2032
6.6.2 Japan OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea OPO-containing Infant Formulas Sales Value, 2021–2032
6.7.2 South Korea OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia OPO-containing Infant Formulas Sales Value, 2021–2032
6.8.2 Southeast Asia OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India OPO-containing Infant Formulas Sales Value, 2021–2032
6.9.2 India OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
6.9.3 India OPO-containing Infant Formulas Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BiosTime
7.1.1 BiosTime Company Information
7.1.2 BiosTime Introduction and Business Overview
7.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BiosTime OPO-containing Infant Formulas Product Offerings
7.1.5 BiosTime Recent Developments
7.2 Nutriben
7.2.1 Nutriben Company Information
7.2.2 Nutriben Introduction and Business Overview
7.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Nutriben OPO-containing Infant Formulas Product Offerings
7.2.5 Nutriben Recent Developments
7.3 Ausnutria
7.3.1 Ausnutria Company Information
7.3.2 Ausnutria Introduction and Business Overview
7.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Ausnutria OPO-containing Infant Formulas Product Offerings
7.3.5 Ausnutria Recent Developments
7.4 HERDS
7.4.1 HERDS Company Information
7.4.2 HERDS Introduction and Business Overview
7.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 HERDS OPO-containing Infant Formulas Product Offerings
7.4.5 HERDS Recent Developments
7.5 Milupa
7.5.1 Milupa Company Information
7.5.2 Milupa Introduction and Business Overview
7.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Milupa OPO-containing Infant Formulas Product Offerings
7.5.5 Milupa Recent Developments
7.6 Shanxi Yatai
7.6.1 Shanxi Yatai Company Information
7.6.2 Shanxi Yatai Introduction and Business Overview
7.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Offerings
7.6.5 Shanxi Yatai Recent Developments
7.7 Beingmate
7.7.1 Beingmate Company Information
7.7.2 Beingmate Introduction and Business Overview
7.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Beingmate OPO-containing Infant Formulas Product Offerings
7.7.5 Beingmate Recent Developments
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Introduction and Business Overview
7.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Abbott OPO-containing Infant Formulas Product Offerings
7.8.5 Abbott Recent Developments
7.9 Brightdairy
7.9.1 Brightdairy Company Information
7.9.2 Brightdairy Introduction and Business Overview
7.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Brightdairy OPO-containing Infant Formulas Product Offerings
7.9.5 Brightdairy Recent Developments
7.10 Feihe
7.10.1 Feihe Company Information
7.10.2 Feihe Introduction and Business Overview
7.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Feihe OPO-containing Infant Formulas Product Offerings
7.10.5 Feihe Recent Developments
7.11 Wyeth Nutrition
7.11.1 Wyeth Nutrition Company Information
7.11.2 Wyeth Nutrition Introduction and Business Overview
7.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Offerings
7.11.5 Wyeth Nutrition Recent Developments
7.12 Deloraine
7.12.1 Deloraine Company Information
7.12.2 Deloraine Introduction and Business Overview
7.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Deloraine OPO-containing Infant Formulas Product Offerings
7.12.5 Deloraine Recent Developments
7.13 Yili
7.13.1 Yili Company Information
7.13.2 Yili Introduction and Business Overview
7.13.3 Yili OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Yili OPO-containing Infant Formulas Product Offerings
7.13.5 Yili Recent Developments
7.14 Kabrita
7.14.1 Kabrita Company Information
7.14.2 Kabrita Introduction and Business Overview
7.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Kabrita OPO-containing Infant Formulas Product Offerings
7.14.5 Kabrita Recent Developments
8 Industry Chain Analysis
8.1 OPO-containing Infant Formulas Industrial Chain
8.2 OPO-containing Infant Formulas Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 OPO-containing Infant Formulas Sales Model
8.5.2 Sales Channels
8.5.3 OPO-containing Infant Formulas Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. OPO-containing Infant Formulas Market Trends
Table 2. OPO-containing Infant Formulas Market Drivers & Opportunities
Table 3. OPO-containing Infant Formulas Market Challenges
Table 4. OPO-containing Infant Formulas Market Restraints
Table 5. Global OPO-containing Infant Formulas Revenue by Company (US$ Million), 2021–2026
Table 6. Global OPO-containing Infant Formulas Revenue Market Share by Company (2021–2026)
Table 7. Global OPO-containing Infant Formulas Sales Volume by Company (K MT), 2021–2026
Table 8. Global OPO-containing Infant Formulas Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market OPO-containing Infant Formulas Price by Company (USD/MT), 2021–2026
Table 10. Key Manufacturers OPO-containing Infant Formulas Manufacturing Base and Headquarters
Table 11. Key Manufacturers OPO-containing Infant Formulas Product Type
Table 12. Key Manufacturers Start of Mass Production of OPO-containing Infant Formulas
Table 13. Global OPO-containing Infant Formulas Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on OPO-containing Infant Formulas revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global OPO-containing Infant Formulas Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global OPO-containing Infant Formulas Sales Value by Type (US$ Million), 2021–2026
Table 18. Global OPO-containing Infant Formulas Sales Value by Type (US$ Million), 2027–2032
Table 19. Global OPO-containing Infant Formulas Sales Market Share in Value by Type (2021–2026)
Table 20. Global OPO-containing Infant Formulas Sales Market Share in Value by Type (2027–2032)
Table 21. Global OPO-containing Infant Formulas Sales Volume by Type: 2021 vs 2025 vs 2032 (K MT)
Table 22. Global OPO-containing Infant Formulas Sales Volume by Type (K MT), 2021–2026
Table 23. Global OPO-containing Infant Formulas Sales Volume by Type (K MT), 2027–2032
Table 24. Global OPO-containing Infant Formulas Sales Market Share in Volume by Type (2021–2026)
Table 25. Global OPO-containing Infant Formulas Sales Market Share in Volume by Type (2027–2032)
Table 26. Global OPO-containing Infant Formulas Price by Type (USD/MT), 2021–2026
Table 27. Global OPO-containing Infant Formulas Price by Type (USD/MT), 2027–2032
Table 28. Global OPO-containing Infant Formulas Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global OPO-containing Infant Formulas Sales Value by Application (US$ Million), 2021–2026
Table 30. Global OPO-containing Infant Formulas Sales Value by Application (US$ Million), 2027–2032
Table 31. Global OPO-containing Infant Formulas Sales Market Share in Value by Application (2021–2026)
Table 32. Global OPO-containing Infant Formulas Sales Market Share in Value by Application (2027–2032)
Table 33. Global OPO-containing Infant Formulas Sales Volume by Application: 2021 vs 2025 vs 2032 (K MT)
Table 34. Global OPO-containing Infant Formulas Sales Volume by Application (K MT), 2021–2026
Table 35. Global OPO-containing Infant Formulas Sales Volume by Application (K MT), 2027–2032
Table 36. Global OPO-containing Infant Formulas Sales Market Share in Volume by Application (2021–2026)
Table 37. Global OPO-containing Infant Formulas Sales Market Share in Volume by Application (2027–2032)
Table 38. Global OPO-containing Infant Formulas Price by Application (USD/MT), 2021–2026
Table 39. Global OPO-containing Infant Formulas Price by Application (USD/MT), 2027–2032
Table 40. Global OPO-containing Infant Formulas Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global OPO-containing Infant Formulas Sales Value by Region (US$ Million), 2021–2026
Table 42. Global OPO-containing Infant Formulas Sales Value by Region (US$ Million), 2027–2032
Table 43. Global OPO-containing Infant Formulas Sales Value by Region (%), 2021–2026
Table 44. Global OPO-containing Infant Formulas Sales Value by Region (%), 2027–2032
Table 45. Global OPO-containing Infant Formulas Sales Volume by Region (K MT): 2021 vs 2025 vs 2032
Table 46. Global OPO-containing Infant Formulas Sales Volume by Region (K MT), 2021–2026
Table 47. Global OPO-containing Infant Formulas Sales Volume by Region (K MT), 2027–2032
Table 48. Global OPO-containing Infant Formulas Sales Volume by Region (%), 2021–2026
Table 49. Global OPO-containing Infant Formulas Sales Volume by Region (%), 2027–2032
Table 50. Global OPO-containing Infant Formulas Average Price by Region (USD/MT), 2021–2026
Table 51. Global OPO-containing Infant Formulas Average Price by Region (USD/MT), 2027–2032
Table 52. Key Countries/Regions OPO-containing Infant Formulas Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions OPO-containing Infant Formulas Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions OPO-containing Infant Formulas Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions OPO-containing Infant Formulas Sales Volume, (K MT), 2021–2026
Table 56. Key Countries/Regions OPO-containing Infant Formulas Sales Volume, (K MT), 2027–2032
Table 57. BiosTime Company Information
Table 58. BiosTime Introduction and Business Overview
Table 59. BiosTime OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 60. BiosTime OPO-containing Infant Formulas Product Offerings
Table 61. BiosTime Recent Developments
Table 62. Nutriben Company Information
Table 63. Nutriben Introduction and Business Overview
Table 64. Nutriben OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 65. Nutriben OPO-containing Infant Formulas Product Offerings
Table 66. Nutriben Recent Developments
Table 67. Ausnutria Company Information
Table 68. Ausnutria Introduction and Business Overview
Table 69. Ausnutria OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 70. Ausnutria OPO-containing Infant Formulas Product Offerings
Table 71. Ausnutria Recent Developments
Table 72. HERDS Company Information
Table 73. HERDS Introduction and Business Overview
Table 74. HERDS OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 75. HERDS OPO-containing Infant Formulas Product Offerings
Table 76. HERDS Recent Developments
Table 77. Milupa Company Information
Table 78. Milupa Introduction and Business Overview
Table 79. Milupa OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 80. Milupa OPO-containing Infant Formulas Product Offerings
Table 81. Milupa Recent Developments
Table 82. Shanxi Yatai Company Information
Table 83. Shanxi Yatai Introduction and Business Overview
Table 84. Shanxi Yatai OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 85. Shanxi Yatai OPO-containing Infant Formulas Product Offerings
Table 86. Shanxi Yatai Recent Developments
Table 87. Beingmate Company Information
Table 88. Beingmate Introduction and Business Overview
Table 89. Beingmate OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 90. Beingmate OPO-containing Infant Formulas Product Offerings
Table 91. Beingmate Recent Developments
Table 92. Abbott Company Information
Table 93. Abbott Introduction and Business Overview
Table 94. Abbott OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 95. Abbott OPO-containing Infant Formulas Product Offerings
Table 96. Abbott Recent Developments
Table 97. Brightdairy Company Information
Table 98. Brightdairy Introduction and Business Overview
Table 99. Brightdairy OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 100. Brightdairy OPO-containing Infant Formulas Product Offerings
Table 101. Brightdairy Recent Developments
Table 102. Feihe Company Information
Table 103. Feihe Introduction and Business Overview
Table 104. Feihe OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 105. Feihe OPO-containing Infant Formulas Product Offerings
Table 106. Feihe Recent Developments
Table 107. Wyeth Nutrition Company Information
Table 108. Wyeth Nutrition Introduction and Business Overview
Table 109. Wyeth Nutrition OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 110. Wyeth Nutrition OPO-containing Infant Formulas Product Offerings
Table 111. Wyeth Nutrition Recent Developments
Table 112. Deloraine Company Information
Table 113. Deloraine Introduction and Business Overview
Table 114. Deloraine OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 115. Deloraine OPO-containing Infant Formulas Product Offerings
Table 116. Deloraine Recent Developments
Table 117. Yili Company Information
Table 118. Yili Introduction and Business Overview
Table 119. Yili OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 120. Yili OPO-containing Infant Formulas Product Offerings
Table 121. Yili Recent Developments
Table 122. Kabrita Company Information
Table 123. Kabrita Introduction and Business Overview
Table 124. Kabrita OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 125. Kabrita OPO-containing Infant Formulas Product Offerings
Table 126. Kabrita Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Key Suppliers of Raw Materials Lists
Table 129. OPO-containing Infant Formulas Downstream Customers
Table 130. OPO-containing Infant Formulas Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. OPO-containing Infant Formulas Product Picture
Figure 2. Global OPO-containing Infant Formulas Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 4. Global OPO-containing Infant Formulas Sales Volume (K MT), 2021–2032
Figure 5. Global OPO-containing Infant Formulas Sales Price (USD/MT), 2021–2032
Figure 6. OPO-containing Infant Formulas Report Years Considered
Figure 7. Global OPO-containing Infant Formulas Players Revenue Ranking (US$ Million), 2025
Figure 8. Global OPO-containing Infant Formulas Sales Volume Ranking of Players (K MT), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by OPO-containing Infant Formulas Revenue in 2025
Figure 10. OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Cow Milk Formula Picture
Figure 12. Goat Milk Formula Picture
Figure 13. Global OPO-containing Infant Formulas Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global OPO-containing Infant Formulas Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global OPO-containing Infant Formulas Sales Volume by Type (K MT), 2021 vs 2025 vs 2032
Figure 16. Global OPO-containing Infant Formulas Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global OPO-containing Infant Formulas Price by Type (USD/MT), 2021–2032
Figure 18. Product Picture of 0 - 6 Month
Figure 19. Product Picture of 6 - 12 Month
Figure 20. Product Picture of 12 - 36 Month
Figure 21. Global OPO-containing Infant Formulas Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global OPO-containing Infant Formulas Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global OPO-containing Infant Formulas Sales Volume by Application (K MT), 2021 vs 2025 vs 2032
Figure 24. Global OPO-containing Infant Formulas Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global OPO-containing Infant Formulas Price by Application (USD/MT), 2021–2032
Figure 26. North America OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 27. North America OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 29. Europe OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific OPO-containing Infant Formulas Sales Value by Region (%), 2025 vs 2032
Figure 32. South America OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 33. South America OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa OPO-containing Infant Formulas Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions OPO-containing Infant Formulas Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions OPO-containing Infant Formulas Sales Volume (%), 2021–2032
Figure 38. United States OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 39. United States OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 40. United States OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 42. Europe OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 44. China OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 45. China OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 46. China OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 48. Japan OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 51. South Korea OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 56. India OPO-containing Infant Formulas Sales Value (US$ Million), 2021–2032
Figure 57. India OPO-containing Infant Formulas Sales Value by Type (%), 2025 vs 2032
Figure 58. India OPO-containing Infant Formulas Sales Value by Application (%), 2025 vs 2032
Figure 59. OPO-containing Infant Formulas Industrial Chain
Figure 60. OPO-containing Infant Formulas Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global OPO-containing Infant Formulas market?
The top companies in the global OPO-containing Infant Formulas market are BiosTime、Nutriben、Ausnutria.
What is the annual compound growth rate of the global OPO-containing Infant Formulas market size from 2026 to 2032?
What was the global market size of OPO-containing Infant Formulas in 2026?
Which region is expected to have the highest market share?
What was the global market size of OPO-containing Infant Formulas in 2032?
Related Reports
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2032
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 157
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 94
USD 4250.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2026
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 125
USD 2900.00
(Single User License)
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2031
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 158
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 96
USD 4250.00
(Single User License)
OPO-containing Infant Formulas - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 118
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2025
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-13
Pages: 93
USD 2900.00
(Single User License)
OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 112
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Insights, Forecast to 2030
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 165
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2024
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 89
USD 2900.00
(Single User License)
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2032
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 157
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 94
USD 4250.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2026
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 125
USD 2900.00 (Single User License)Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2031
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 158
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 96
USD 4250.00 (Single User License)OPO-containing Infant Formulas - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 118
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2025
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-13
Pages: 93
USD 2900.00 (Single User License)OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 112
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Insights, Forecast to 2030
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 165
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2024
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now